Athanasia Alexoudi - Concepedia

Author

Athanasia Alexoudi

National and Kapodistrian University of Athens ORCID

Also Known As

A Alexoudi, A. Alexoudi, A. Siatouni, Alexoudi, Athanasia, Athanasia Alexoudi, Francesca Notturno

Publications

589

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Evangelismos Hospital National Centre of Scientific Research "Demokritos"Universitätsklinikum Erlangen Christian-Albrechts-Universität zu Kiel

About

Athanasia Alexoudi is an author at National and Kapodistrian University of Athens specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	111
2	Public Health	2	2	37
3	Social Sciences	1	1	12
4	Epidemiology	1	1	12
5	Immunology	1	1	19

Athanasia Alexoudi

Publications

251

Citations

H-Index

Page 1

	Year	Citations
Circulating miR‐146a and miR‐134 in predicting drug‐resistant epilepsy in patients with focal impaired awareness seizures Maria Leontariti, Margaritis Avgeris, Martha‐Spyridoula Katsarou, Epilepsia	2020	52
The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus Ali Shalash, Athanasia Alexoudi, Karina Knudsen, Parkinsonism & Related Disorders Disease DurationNeurodegenerative DiseasesCorticobasal DegenerationNeuroanatomyMedicine	2013	45
Spastic paraplegia preceding <i>PSEN1</i>‐related familial Alzheimer's disease Viorica Chelban, Marianthi Breza, María Szaruga, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2021	20
Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis. Athanasia Alexoudi, Sophia Zachaki, Chrysa Stavropoulou, PubMed Natalizumab AdministrationDisease ProgressionImmunologyGenetic EpidemiologyPathology	2016	19
The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease Chrysa Stavropoulou, Sophia Zachaki, Athanasia Alexoudi, Free Radical Biology and Medicine Disease SusceptibilityMedicineGeneticsC609t Inborn PolymorphismGenetic Epidemiology	2011	18
The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation Athanasia Alexoudi, Ali Shalash, Karina Knudsen, Parkinsonism & Related Disorders Subthalamic NeurostimulationMedical TreatmentCorticobasal DegenerationNeurological DisorderParkinson Disease	2015	17
Epileptic Patient with Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia and Epilepsy (MOGHE): A Case Report and Review of the Literature Anastasia Verentzioti, Ingmar Blümcke, Athanasia Alexoudi, Case Reports in Neurological Medicine	2019	16
Pharmacokinetic and pharmacodynamic modeling of levetiracetam: investigation of factors affecting the clinical outcome Eleni Karatza, Sophia L. Markantonis, Andria Savvidou, Xenobiotica	2020	15
Effects of anodal tDCS on motor and cognitive function in a patient with multiple system atrophy Athanasia Alexoudi, Panayiotis Patrikelis, Theodoros Fasilis, Disability and Rehabilitation	2018	14
Combined<i>GSTP1</i>and<i>NQO1</i>germline polymorphisms in the susceptibility to Multiple Sclerosis Athanasia Alexoudi, Sophia Zachaki, Chrysa Stavropoulou, International Journal of Neuroscience	2014	13

Page 1